Influenza A outbreak of Tai lung drug industry received 400,000 boxes of drug orders

As of yesterday, the mainland has confirmed three imported swine flu cases, in this respect, our Ministry of Health research has formulated the corresponding plan, and began to some pharmaceutical companies to issue preventive treatment for swine flu reserve products orders. Yesterday, there is news that Tai Lung medicine has received shuanghuanglian drug orders.　　This news, Tai Lung pharmaceutical stocks on the day of the seal died in the trading board. Yesterday, the "Volkswagen Securities newspaper" In this regard for a variety of textual verification.　　According to an insider from Tai Lung Pharmaceutical, the company did get a 400,000-box first order. The person said, recently, the Chinese Medicine group received a notice issued by the Superior department, require the reserve of a group of Shuanghuanglian oral preparations for the Chinese medicine for swine flu, and the reserve products, and Tai Lung pharmaceutical and China Pharmaceutical group has been business dealings, so the Chinese medicine group to the batch of Shuanghuanglian oral preparations to the production of Tai Lung. However, 400,000 boxes of orders are not large, such as Tai Long professional manufacturers, as long as about two days to output.　　Future will not have this order, the key is to see the development of influenza A. Yesterday, Gufangqing, an analyst with the joint Securities and pharmaceutical industry, also confirmed to the Volkswagen Securities journal Tai Lung Medicine did get a swine flu preventive treatment orders, but its share price in Monday, in the final analysis is still benefiting from the impact of the continuation of the theme of influenza A pandemic, last week, the rise of the Great Gene, Rhine biology in Monday to stop the plate,　　This is the market in the release of the risk of the signal, in the face of such trading opportunities, investors should be cautious to operate enough. Reporter Zhang Yi Xu Xian